Skip to main content Help with accessibility Skip to main navigation

Omalizumab

Indication

Severe chronic inducible urticarias

Red

Brand:

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Skin

Background

LSCMMG supports use of omalizumab in unlicensed indications of severe chronic inducible urticarias (solar urticaria, cold and heat urticaria, symptomatic dermographism, delayed pressure urticaria and cholinergic urticaria) in adults as an option as add-on therapy only if the attached conditions are met.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Unlicensed use of omalizumab for severe chronic inducible urticarias: commissioning statement

Decisions of Lancashire local decision making groups

BwD
BP
CSR
EL
FW
GP
MB
WL
Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 18 - Dec - 2024